https://www.ecoflow.com/us/blog/saving-money-with-shp2
Maximize Savings with EcoFlow DPU + SHP2
Learn how to integrate EcoFlow DPU + SHP2 with your existing rooftop PV system for cost savings and reliable backup power without altering your current setup.
maximizesavingsecoflowdpushp2
https://pmc.ncbi.nlm.nih.gov/articles/PMC22373/
Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2 - PMC
The SH2 domain-containing tyrosine phosphatase Shp2 plays a pivotal role during the gastrulation of vertebrate embryos. However, because of the complex...
tyrosine phosphatasemorphogeneticmovementsgastrulationrequire
https://www.rcsb.org/structure/6CMQ
RCSB PDB - 6CMQ: Structure of human SHP2 without N-SH2 domain
Structure of human SHP2 without N-SH2 domain
rcsb pdbstructure
https://www.ncbi.nlm.nih.gov/Structure/pdb/5IBM
5IBM: Structure of S502P, a Cancer-Associated Mutation of the Oncogenic Phosphatase SHP2
Tyrosine-protein phosphatase non-receptor type 11
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.851930/full
Frontiers | Study on the SHP2-Mediated Mechanism of Promoting Spermatogenesis Induced by Active...
Spermatogenesis directly determines the reproductive capacity of male animals. With the development of society, the increasing pressure on people's lives and...
https://elifesciences.org/articles/104060
Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric...
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but...
https://elifesciences.org/reviewed-preprints/103615v1/figures
Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development
https://www.rcsb.org/structure/8S06
RCSB PDB - 8S06: A fragment-based inhibitor of SHP2
A fragment-based inhibitor of SHP2
rcsb pdbfragmentbasedinhibitorshp2
https://www.ncbi.nlm.nih.gov/Structure/pdb/4QSY
4QSY: SHP2 SH2 domain in complex with GAB1 peptide
GRB2-associated-binding protein 1Tyrosine-protein phosphatase non-receptor type 11
sh2 domainshp2complexgab1peptide
https://www.mdpi.com/1420-3049/28/19/6947
Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity
Src homology 2 domain-containing phosphatase 2 (SHP2) is an attractive target for cancer therapy due to its multifaceted roles in both tumor and immune cells....
discovery ofwith inanti tumorshp2degrader
https://www.ncbi.nlm.nih.gov/Structure/pdb/8GWW
8GWW: Small-molecule Allosteric Regulation Mechanism of SHP2
Tyrosine-protein phosphatase non-receptor type...
small moleculeallosteric regulationmechanismshp2
https://www.fiercebiotech.com/biotech/genentech-sinks-shp2-pact-leaving-relay-race-thinning-field
Genentech sinks SHP2 pact, leaving Relay to race thinning field
Jul 17, 2024 - Genentech has scuttled its SHP2 inhibitor pact, returning the rights to Relay Therapeutics after plowing more than $120 million into the alliance.
genentechsinksshp2pactleaving
https://pmc.ncbi.nlm.nih.gov/articles/PMC12905148/
SHP2 promotes osteosarcoma via regulating STAT3/TET3/HOXB2 signaling - PMC
To investigate the effect of SHP2 on the STAT3/TET3/HOXB2 signaling pathway in osteosarcoma, and its role in the proliferation, migration and invasion of...
shp2osteosarcomaviaregulatingstat3
https://www.ebi.ac.uk/chembl/explore/document/CHEMBL4699491
Document: Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer....
Report card for Document Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. (CHEMBL4699491). J Med Chem, SHP2 is a nonreceptor...
https://www.thermofisher.com/antibody/product/SHP2-Antibody-Polyclonal/20145-1-AP
SHP2 Polyclonal Antibody | Invitrogen (20145-1-AP)
Detect SHP2 in WB, ICC/IF, IHC (P), ELISA, Flow. Reacts with Rabbit, Mouse, Goat, Rat. Cited in 29 publications. Catalog # 20145-1-AP
polyclonal antibodyshp2invitrogen1ap
https://www.benzinga.com/general/biotech/22/05/27163467/bridgebio-inks-licensing-pact-with-bristol-myers-for-shp2-inhibitor-in-oncology
BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology - BridgeBio Pharma...
https://www.rcsb.org/structure/5X7B
RCSB PDB - 5X7B: Crystal structure of SHP2_SH2-CagA EPIYA_C peptide complex
Crystal structure of SHP2_SH2-CagA EPIYA_C peptide complex
https://www.ncbi.nlm.nih.gov/Structure/pdb/5X94
5X94: Crystal structure of SHP2_SH2-CagA EPIYA_D peptide complex
Cag pathogenicity island proteinTyrosine-protein phosphatase non-receptor type 11
crystal structured peptideshp2